Add Neisseria meningitidis back

sanger-pathogens · May 3, 2023 · 60b6ab7 · 60b6ab7
1 parent a4583c3
commit 60b6ab7
Show file tree

Hide file tree

Showing 3 changed files with 7 additions and 0 deletions.
diff --git a/public/logos/meningococcus.png b/public/logos/meningococcus.png
diff --git a/src/components/ResearchThemes.js b/src/components/ResearchThemes.js
@@ -7,6 +7,7 @@ import Collapsible from './Collapsible';
 const mdResearchIntro = raw('../content/research-intro.md');
 const mdResearchGPS = raw('../content/research-gps.md');
 const mdResearchJUNO = raw('../content/research-juno.md');
+const mdResearchMeningococcus = raw('../content/research-meningococcus.md');
 
 const ResearchThemes = () => {
   return (
@@ -18,6 +19,9 @@ const ResearchThemes = () => {
       <Collapsible title='Streptococcus agalactiae' logo='logos/juno-logo.png'>
         <Markdown md={mdResearchJUNO} />
       </Collapsible>
+      <Collapsible title='Neisseria meningitidis' logo='logos/meningococcus.png'>
+        <Markdown md={mdResearchMeningococcus} />
+      </Collapsible>
     </div>
   );
 };

diff --git a/src/content/research-meningococcus.md b/src/content/research-meningococcus.md
@@ -0,0 +1,3 @@
+*Neisseria meningitidis* is found exclusively in humans and is a leading cause of bacterial meningitis and septicaemia. Meningococcal infections are difficult to treat and have a high case fatality rate but, as with the pneumococcus, colonisation is normally asymptomatic. The meningococcus has a substantial disease burden in the meningitis belt of sub-Saharan Africa, where the incidence of infection and disease are much higher than other regions of the world. We work with numerous collaborators to study several population genomic datasets of *N. meningitidis* including a large carriage collection from [Burkina Faso](https://www.ncbi.nlm.nih.gov/pubmed/23914778) (with [Dominique Caugant](http://www.menafrinet.org/en-us/Who/Advisory-Board)), the [MenAfriCar](https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(17)30301-8/fulltext) meningitis belt carriage surveillance project, and a global collection of carriage and disease isolates with considerable temporal spread. Through these studies we hope to understand the evolution that leads to meningococcal disease epidemics in the Meningitis Belt and help to inform future vaccine intervention strategies worldwide.
+
+*Image: Arthur Charles-Orszag, [Neisseria meningitidis](https://commons.wikimedia.org/wiki/File:Neisseria_meningitidis_Charles-Orszag_2018.png), [CC BY-SA 4.0](https://creativecommons.org/licenses/by-sa/4.0/legalcode)*
Original file line number	Diff line number	Diff line change
		@@ -0,0 +1,3 @@
		Neisseria meningitidis is found exclusively in humans and is a leading cause of bacterial meningitis and septicaemia. Meningococcal infections are difficult to treat and have a high case fatality rate but, as with the pneumococcus, colonisation is normally asymptomatic. The meningococcus has a substantial disease burden in the meningitis belt of sub-Saharan Africa, where the incidence of infection and disease are much higher than other regions of the world. We work with numerous collaborators to study several population genomic datasets of N. meningitidis including a large carriage collection from [Burkina Faso](https://www.ncbi.nlm.nih.gov/pubmed/23914778) (with [Dominique Caugant](http://www.menafrinet.org/en-us/Who/Advisory-Board)), the [MenAfriCar](https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(17)30301-8/fulltext) meningitis belt carriage surveillance project, and a global collection of carriage and disease isolates with considerable temporal spread. Through these studies we hope to understand the evolution that leads to meningococcal disease epidemics in the Meningitis Belt and help to inform future vaccine intervention strategies worldwide.

		Image: Arthur Charles-Orszag, [Neisseria meningitidis](https://commons.wikimedia.org/wiki/File:Neisseria_meningitidis_Charles-Orszag_2018.png), [CC BY-SA 4.0](https://creativecommons.org/licenses/by-sa/4.0/legalcode)